I enjoy looking at and attempting to understand charts & recently began posting some of my own. HOWEVER, I'm not a professional nor do I pretend to be one. Always remember, it's your trade alone. Know why you made it!
â€œThe naive believe everything, but a wise man looks well into a matter.â€ -King Soloman *Proverbs 14:15* I've been trading stocks and commodities for a couple years now. I also sell cars and can deliver to any state in America.
Robert Alexander, better known as ‘Alex’ in trading forums, has been a full time trader for over a decade. Focusing on breakouts and volume, developing a unique view of charting that has served him extremely well.
Primary interest is Bio with intriguing pipelines that have large growth potential. I attempt to hold >50% of positions LT unless negative data, mgmt. concerns, or known negative events. Diversify and only trade in spec what you can lose.
Rule #1 - 2 stocks overnight MAX (3rd only if next day PM sell)
Rule #2 - 1 biotech LT, scalp rest
Rule #3 - 0 losses, DD never fails you.
All other trades are intra-day scalps only. Sup/Res, volume, news, momo..profit from it w/ ZERO emotions.
Paramedic, Nerd, Dedicated researcher of biotech companies. Position Trader. The harder you work, the luckier you will become. Disclaimer: I am not a registered advisor so please always do your own DD. Enjoy life!
Market Intelligence ★ Former Wall Street ★ Research
-- "Taking Knowledge From The Smart Money" (Smart Institutions, Hedge Funds, Analysts, Traders, Drs, PhD's, CEOs, HNW and SHNW Investors, Etc) --
Funnel down research to make better stock picks.
Investor and Day Trader. Trade based on TA with focus on minimising risk and locking gains. Invest in undervalued tech w/ insane growth (my background).
Helping the Little Guy out by sharing my trade ideas for free and in real time on ST.
Unlike day-trading which is based solely on technical analysis, we identify Story Trades by combining headline news, fundamental analysis, technical analysis, & social sentiment to achieve superior returns. 100% ROE in 2013. 200% in 2014.